| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-10 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.44 | 6e-10 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.4 | 3e-08 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.4 | 4e-08 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.32 | 4e-08 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |